Insmed (INSM) Q3 2026 Earnings Call: Leadership Strategy
Insmed Incorporated held its Q3 2026 earnings conference call on Wednesday, October 29, 2026, detailing its operational pivot into a diversified biotechnology firm. President, CEO, and Chairman Will Lewis, alongside CFO Sara Bonstein and CMO Martina Flammer, outlined the company's financial standing and pipeline positioning for institutional investors.
Leadership change — watch $INSM+WL for succession / guidance risk.